Target intelligence / Profile preview

Bacterial and viral surface proteins

Molecular classification
Receptor (viral entry proteins, e.g., HIV-1 gp120 bind CD4 receptor), Enzyme (some bacterial surface proteins are enzymes), Other (capsid proteins, envelope proteins, outer membrane proteins)
01

Overview

Bacterial and viral surface proteins comprise a large and diverse group of molecules exposed on the exterior of bacteria or viruses, including viral envelope proteins, capsid proteins, and bacterial membrane proteins. These proteins mediate critical biological functions, such as the recognition and binding of host cells, immune evasion, and facilitating entry into host cells. They are major therapeutic and vaccine targets and exhibit considerable variation in sequence and structure. For viruses, examples include the spike proteins of influenza and coronaviruses, and for bacteria, surface proteins may include adhesins, invasins, or enzymes. Their high immunogenicity makes them key biomarkers, but also presents therapeutic challenges due to rapid antigenic shifting and genetic variability. For structured bioinformatic applications, it is recommended to specify a particular protein (e.g., "Influenza hemagglutinin" or "HIV-1 gp120") instead of referring to the general class "Bacterial and viral surface proteins," to avoid ambiguity and ensure scientific rigor.

Other names
viral envelope proteinbacterial outer membrane proteinviral spike proteinbacterial surface antigencapsid protein
02

Mechanism of action

Blocking surface protein-receptor interaction (prevents pathogen attachment and entry); Neutralizing pathogen via antibody binding (for viruses and bacteria); Inhibiting enzymatic activity (for bacterial surface enzymes)

03

Biological functions

Immune response (targets of host antibodies and vaccines)Host cell recognition and bindingSignal transduction (in some bacterial systems)Infection (mediate entry of pathogen into host cells)
04

Disease associations

Infection (bacterial and viral pathogens)Inflammation (via immune activation)Other (autoimmune responses, sepsis)
05

Safety considerations

Antigenic variability (surface proteins can rapidly mutate in viruses and some bacteria, leading to immune evasion)Potential for autoimmune responses (molecular mimicry)Off-target effects (cross-reactivity with host proteins)
06

Interacting drugs

Antibodies (e.g., monoclonal antibodies against SARS-CoV-2 spike protein)

2 more in the full profile.

07

Biomarkers

Surface antigens (e.g., influenza hemagglutinin, HIV-1 gp120) used in diagnostic testsSerologic detection of pathogen-specific antibodies

Beyond the preview

Go deeper on Bacterial and viral surface proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and viral surface proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call